DEPDC5 (GATOR1 complex protein DEPDC5) variants and mutations
DEPDC5 (also known as GATOR1 complex protein DEPDC5) is a human protein-coding gene encoding a GATOR1 complex protein. It is part of the GATOR1 complex, which restrains mTORC1 activity when amino acids are limited. Loss-of-function variants cause focal epilepsy with variable penetrance and can contribute to focal cortical dysplasia through somatic second-hit events. This analysis covers 2,181 DEPDC5 variants and mutations. Of these, 71% have computational variant effect predictions. Disease context includes familial focal epilepsy with variable foci, epilepsy, familial focal, with variable foci 1, and developmental and epileptic encephalopathy 111. Example DEPDC5 variants include M1?, R2G, and R2K.
Variant analysis overview
- Gene: DEPDC5
- Protein: GATOR1 complex protein DEPDC5
- UniProt accession: O75140
- Organism: Homo sapiens
- Variants analyzed: 2181
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 2,075 unspecified-consequence records; 1 in-frame deletions; 42 missense variants; 56 synonymous variants; 1 frameshift variants; 4 splice-region variants; 1 in-frame insertions; 1 substitution
- Prediction scores: 1,557 variants have prediction scores (71% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: familial focal epilepsy with variable foci, epilepsy, familial focal, with variable foci 1, developmental and epileptic encephalopathy 111, hereditary disease, Seizure, epilepsy, autosomal dominant nocturnal frontal lobe epilepsy, Rolandic epilepsy, self-limited epilepsy with centrotemporal spikes, focal epilepsy, Abnormality of the skeletal system, Focal cortical dysplasia.
Protein structure and variant hotspots
- Protein features: 1 domains; 3 post-translational modification sites.
- Structural context: 114 variants have structural context.
- PTM context: 3 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable DEPDC5 variants
Examples include M1?, R2G, R2K, T3I, T3R, T3S, p.Thr4del, T4T. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, rs2147930155, ClinGen CA411277771, ClinVar RCV002027880, NCI-TCGA TCGA novel, MetaLR 0.24, MetaSVM -0.58, Uncertain significance
- R2G (p.Arg2Gly), gnomAD rs1392887985, CADD 25.20, PolyPhen-2 0.01
- R2K (p.Arg2Lys), rs756142773, ClinGen CA10195778, ClinVar RCV000459734, ClinVar RCV001193557, CADD 18.50, PolyPhen-2 0.00, Conflicting interpretations, Familial focal epilepsy with variable foci; Inborn genetic diseases; not specifi
- T3I (p.Thr3Ile), cosmic curated COSV56705
- T3R (p.Thr3Arg), TOPMed rs1388342675, gnomAD rs1388342675, CADD 25.40
- T3S (p.Thr3Ser), gnomAD 22-31754928-A-T, CADD 25.00, PolyPhen-2 0.11
- T4del (p.Thr4del), rs2075190242, gnomAD 22-31754926-GAAC-, CADD 20.90
- T4T (p.Thr4Thr), rs2075190658, gnomAD 22-31754933-A-G, CADD 10.90
- K5R (p.Lys5Arg), rs372506941, ClinGen CA10195779, cosmic curated COSV56690, ClinVar RCV003091358, CADD 22.80, PolyPhen-2 0.01, Uncertain significance, Familial focal epilepsy with variable foci; not provided
- K5K (p.Lys5Lys), gnomAD 22-31754936-G-A, CADD 10.10
- V6I (p.Val6Ile), gnomAD rs2075191238, CADD 23.20, PolyPhen-2 0.14, Uncertain significance, not provided
- V6A (p.Val6Ala), gnomAD 22-31754938-T-C, CADD 23.80, PolyPhen-2 0.02
- Y7* (p.Tyr7Ter), rs768241563, ClinGen CA10195781, ClinVar RCV000043579, ClinVar RCV001034641, CADD 36.00, Pathogenic
- Y7C (p.Tyr7Cys), rs748813142, ClinGen CA10195780, ClinVar RCV002232303, ClinVar RCV002528406, CADD 28.60, PolyPhen-2 0.99, Uncertain significance, Inborn genetic diseases; Familial focal epilepsy with variable foci
- Y7H (p.Tyr7His), gnomAD rs2075191658, CADD 29.50, PolyPhen-2 0.98
- L9F (p.Leu9Phe), gnomAD rs2075192115, CADD 25.80
- L9V (p.Leu9Val), gnomAD 22-31754946-C-G, CADD 25.00, PolyPhen-2 0.99
- L9P (p.Leu9Pro), gnomAD 22-31754947-T-C, CADD 29.70, PolyPhen-2 1.00
- L9L (p.Leu9Leu), rs778731999, gnomAD 22-31754948-C-T, CADD 4.57
- V10I (p.Val10Ile), rs375027042, ClinGen CA10195783, ClinVar RCV000480624, ClinVar RCV000555417, CADD 23.40, PolyPhen-2 0.65, Uncertain significance, not provided; Familial focal epilepsy with variable foci
- H12Q (p.His12Gln), TOPMed rs2075192968, gnomAD rs2075192968, CADD 24.80
- K13K (p.Lys13Lys), gnomAD 22-31754960-G-A, CADD 15.20
- K14K (p.Lys14Lys), rs369133508, gnomAD 22-31754963-G-A, CADD 11.90
- G15A (p.Gly15Ala), ExAC rs777122777, gnomAD rs777122777, CADD 26.60, PolyPhen-2 0.91
- G15G (p.Gly15Gly), rs373199155, gnomAD 22-31754966-C-T, CADD 13.20
- F16I (p.Phe16Ile), gnomAD 22-31754967-T-A, CADD 29.00, PolyPhen-2 0.99
- F16F (p.Phe16Phe), gnomAD 22-31754969-T-C, CADD 14.10
- G17V (p.Gly17Val), rs2517655499, ClinGen CA411278047, ClinVar RCV002287065, Uncertain significance, not provided
- G17G (p.Gly17Gly), rs2075194052, gnomAD 22-31754972-G-A, CADD 13.40
- G18S (p.Gly18Ser), gnomAD rs1357795419, CADD 23.40, PolyPhen-2 0.38
- G18A (p.Gly18Ala), rs1569505090, gnomAD 22-31754969-TG-T, CADD 32.00
- G18D (p.Gly18Asp), gnomAD 22-31754974-G-A, CADD 27.70, PolyPhen-2 0.94
- G18G (p.Gly18Gly), rs1375264234, gnomAD 22-31754975-C-T, CADD 18.10
- S19T (p.Ser19Thr), rs886039275, ClinGen CA10588019, ClinVar RCV000254616, Ensembl rs886039275, AlphaMissense 0.13, MetaLR 0.26, not provided, Epilepsy, familial focal, with variable foci 1
- D21H (p.Asp21His), gnomAD 22-31758548-G-C, CADD 28.10, PolyPhen-2 0.97
- D21E (p.Asp21Glu), gnomAD 22-31758550-T-A, CADD 23.00, PolyPhen-2 0.82
- E22K (p.Glu22Lys), TOPMed rs2082123455
- E22E (p.Glu22Glu), rs749841723, gnomAD 22-31758553-G-A, CADD 8.35
- L23V (p.Leu23Val), gnomAD 22-31758554-C-G, CADD 22.90, PolyPhen-2 0.99
- L23L (p.Leu23Leu), rs1440966754, gnomAD 22-31758554-C-T, CADD 8.70
- V24G (p.Val24Gly), rs572660873, ClinGen CA10195811, ClinVar RCV000475980, ClinVar RCV003925352, CADD 24.40, PolyPhen-2 0.30, Benign/Likely benign, Familial focal epilepsy with variable foci; not provided
- N26D (p.Asn26Asp), ExAC rs761783252, gnomAD rs761783252, CADD 27.00, PolyPhen-2 0.98
- P27L (p.Pro27Leu), rs1485949754, ClinGen CA411278811, ClinVar RCV001352379, TOPMed rs1485949754, AlphaMissense 0.57, MetaLR 0.23, Uncertain significance, Familial focal epilepsy with variable foci
- P27R (p.Pro27Arg), TOPMed rs1485949754, gnomAD rs1485949754, AlphaMissense 0.57, MetaLR 0.23, Uncertain significance
- P27P (p.Pro27Pro), gnomAD 22-31758568-C-T, CADD 9.07
- K28E (p.Lys28Glu), rs2082124844, ClinGen CA411278816, ClinVar RCV001208772, Ensembl rs2082124844, AlphaMissense 0.59, MetaLR 0.17, Uncertain significance, Familial focal epilepsy with variable foci
- K28R (p.Lys28Arg), rs2517738867, ClinGen CA411278821, ClinVar RCV002585199, Uncertain significance, Familial focal epilepsy with variable foci
- V29A (p.Val29Ala), TOPMed rs1157334235, gnomAD rs1157334235, CADD 24.00
- V29V (p.Val29Val), gnomAD 22-31758574-G-A, CADD 7.20
- F30L (p.Phe30Leu), rs374794334, ClinGen CA10195813, ClinVar RCV000797983, ClinVar RCV004997334, CADD 24.00, PolyPhen-2 0.98, Uncertain significance, Familial focal epilepsy with variable foci; not provided
- F30F (p.Phe30Phe), rs374794334, gnomAD 22-31758577-C-T, CADD 10.60
- P31L (p.Pro31Leu), TOPMed rs1435688202, gnomAD rs1435688202, CADD 22.10, PolyPhen-2 0.01
- P31A (p.Pro31Ala), gnomAD 22-31758578-C-G, CADD 22.90, PolyPhen-2 0.12
- P31P (p.Pro31Pro), gnomAD 22-31758580-T-C, CADD 12.00
- H32D (p.His32Asp), TOPMed rs1305007186, gnomAD rs1305007186, AlphaMissense 0.08, MetaLR 0.04, Uncertain significance
- H32R (p.His32Arg), rs760541660, ClinGen CA10195815, ClinVar RCV001349880, ClinVar RCV002471091, CADD 21.80, PolyPhen-2 0.01, Uncertain significance, Inborn genetic diseases; Epilepsy, familial focal, with variable foci 1; Familia
- H32Y (p.His32Tyr), rs1305007186, ClinGen CA411278851, ClinVar RCV002300710, TOPMed rs1305007186, AlphaMissense 0.08, MetaLR 0.04, Uncertain significance, not provided
- I33V (p.Ile33Val), rs368035159, ClinGen CA323318190, ClinVar RCV002010837, ESP rs368035159, CADD 17.10, PolyPhen-2 0.00, Uncertain significance, Familial focal epilepsy with variable foci
- K34K (p.Lys34Lys), rs766327865, gnomAD 22-31758589-G-A, CADD 10.10
- L35F (p.Leu35Phe), cosmic curated COSV10455
- G36R (p.Gly36Arg), ESP rs370544271, ExAC rs370544271, TOPMed rs370544271, gnomAD rs370544271
- D37G (p.Asp37Gly), TOPMed rs1280310409, gnomAD rs1280310409, CADD 27.30, PolyPhen-2 0.04
- D37N (p.Asp37Asn), cosmic curated COSV56702
- D37D (p.Asp37Asp), gnomAD 22-31758598-C-T, CADD 8.97
- I38M (p.Ile38Met), rs566463688, ClinGen CA10195819, ClinVar RCV001370491, ClinVar RCV001773730, CADD 22.70, PolyPhen-2 0.35, Uncertain significance, Familial focal epilepsy with variable foci; Inborn genetic diseases; not provide
- I38T (p.Ile38Thr), rs1023389808, ClinGen CA323318196, ClinVar RCV003110368, ClinVar RCV003340660, AlphaMissense 0.48, MetaLR 0.12, Uncertain significance, Familial focal epilepsy with variable foci; Epilepsy, familial focal, with varia
- I38V (p.Ile38Val), ExAC rs755036534, gnomAD rs755036534, CADD 19.10, PolyPhen-2 0.00
- I38S (p.Ile38Ser), gnomAD 22-31758600-T-G, CADD 26.40, PolyPhen-2 0.18
- I38I (p.Ile38Ile), rs566463688, gnomAD 22-31758601-T-C, CADD 9.59
- V39L (p.Val39Leu), cosmic curated COSV99836
- V39I (p.Val39Ile), gnomAD 22-31758602-G-A, CADD 23.20, PolyPhen-2 0.01
- E40E (p.Glu40Glu), gnomAD 22-31758607-G-A, CADD 9.97
- I41M (p.Ile41Met), gnomAD rs1306949358, CADD 23.10, PolyPhen-2 1.00
- I41V (p.Ile41Val), gnomAD 22-31758608-A-G, CADD 25.00, PolyPhen-2 0.96
- H43P (p.His43Pro), ExAC rs757783508
- H43Q (p.His43Gln), rs763669717, ClinGen CA10195822, ClinVar RCV003595229, ExAC rs763669717, CADD 18.70, PolyPhen-2 0.26, Uncertain significance, Familial focal epilepsy with variable foci
- H43Y (p.His43Tyr), ESP rs375173943, ExAC rs375173943, TOPMed rs375173943, gnomAD rs375173943, CADD 24.80, PolyPhen-2 0.88
- P44A (p.Pro44Ala), rs756878843, ClinGen CA10195824, ClinVar RCV000991880, ClinVar RCV002234536, CADD 24.00, PolyPhen-2 1.00, Uncertain significance, Familial focal epilepsy with variable foci; not provided
- P44S (p.Pro44Ser), rs756878843, ClinGen CA411279005, ClinVar RCV003595310, ExAC rs756878843, CADD 24.50, PolyPhen-2 1.00, Uncertain significance, Familial focal epilepsy with variable foci
- P44P (p.Pro44Pro), rs1601581899, gnomAD 22-31758619-C-T, CADD 8.85
- N45I (p.Asn45Ile), cosmic curated COSV56711
- N45K (p.Asn45Lys), ESP rs368243595, ExAC rs368243595, TOPMed rs368243595, gnomAD rs368243595, CADD 1.83, PolyPhen-2 0.13, Likely benign
- N45S (p.Asn45Ser), rs2517740331, ClinGen CA411279019, ClinVar RCV003209518, CADD 18.40, PolyPhen-2 0.01, Uncertain significance, Inborn genetic diseases
- N45T (p.Asn45Thr), cosmic curated COSV10723
- N45Y (p.Asn45Tyr), ExAC rs780433877, gnomAD rs780433877
- N45N (p.Asn45Asn), rs368243595, gnomAD 22-31758622-C-T, CADD 0.60
- D46E (p.Asp46Glu), rs535630975, ClinGen CA10195828, ClinVar RCV001434051, ClinVar RCV003960330, CADD 22.50, PolyPhen-2 0.28, Likely benign, Familial focal epilepsy with variable foci; Inborn genetic diseases; not provide
- D46N (p.Asp46Asn), cosmic curated COSV10585, TOPMed rs956844670, gnomAD rs956844670, CADD 25.10, PolyPhen-2 0.94, Uncertain significance, Familial focal epilepsy with variable foci
- D46V (p.Asp46Val), rs769208150, ClinGen CA10195827, ClinVar RCV002585395, ClinVar RCV003883881, CADD 24.80, PolyPhen-2 0.96, Uncertain significance, Familial focal epilepsy with variable foci; not provided
- D46D (p.Asp46Asp), gnomAD 22-31758625-T-C, CADD 9.36
- E47G (p.Glu47Gly), rs2082129391, ClinGen CA411279047, ClinVar RCV001337786, Ensembl rs2082129391, AlphaMissense 0.34, MetaLR 0.23, Uncertain significance, Familial focal epilepsy with variable foci
- E47K (p.Glu47Lys), cosmic curated COSV56708
- Y48H (p.Tyr48His), gnomAD 22-31758629-T-C, CADD 24.70, PolyPhen-2 0.64
- Y48Y (p.Tyr48Tyr), gnomAD 22-31758631-C-T, CADD 15.70
- S49I (p.Ser49Ile), NCI-TCGA Cosmic COSV9983, cosmic curated COSV99834, Variant assessed as somatic; moderate impact.
- P50S (p.Pro50Ser), TOPMed rs1457991619, gnomAD rs1457991619, CADD 24.70, PolyPhen-2 0.79
- P50R (p.Pro50Arg), gnomAD 22-31760658-C-G, CADD 22.20, PolyPhen-2 0.20
- P50P (p.Pro50Pro), rs776930253, gnomAD 22-31760659-T-C, CADD 12.10
- L51V (p.Leu51Val), NCI-TCGA Cosmic COSV5669, cosmic curated COSV56696, Variant assessed as somatic; moderate impact.
- L52H (p.Leu52His), rs2148027396, ClinGen CA411279577, ClinVar RCV001360758, Ensembl rs2148027396, AlphaMissense 0.98, MetaLR 0.27, Uncertain significance, Familial focal epilepsy with variable foci
- L52L (p.Leu52Leu), rs1388547069, gnomAD 22-31760665-T-G, CADD 8.52
- L53S (p.Leu53Ser), rs2517796670, ClinGen CA411279588, ClinVar RCV003324950, Uncertain significance, not provided
- Q54H (p.Gln54His), TOPMed rs1329749085, gnomAD rs1329749085, CADD 22.10
- Q54P (p.Gln54Pro), rs201312113, ClinGen CA10195853, cosmic curated COSV56695, ClinVar RCV000254580, CADD 26.30, PolyPhen-2 0.99, Benign, Inborn genetic diseases; not provided; Familial focal epilepsy with variable foc
- V55F (p.Val55Phe), ExAC rs769423746, gnomAD rs769423746, CADD 26.30, PolyPhen-2 0.99
- V55L (p.Val55Leu), ExAC rs769423746, gnomAD rs769423746, CADD 25.70, PolyPhen-2 0.91
- V55V (p.Val55Val), rs762835700, gnomAD 22-31760674-C-G, CADD 8.32
- K56E (p.Lys56Glu), TOPMed rs2082314898, gnomAD rs2082314898, CADD 27.00, Uncertain significance, Familial focal epilepsy with variable foci
- K56R (p.Lys56Arg), rs966689579, ClinGen CA323320371, ClinVar RCV000798704, TOPMed rs966689579, CADD 25.50, PolyPhen-2 0.95, Uncertain significance, Familial focal epilepsy with variable foci
- p.Lys56dup, gnomAD 22-31760674-C-CAA, CADD 20.60
- K56K (p.Lys56Lys), gnomAD 22-31760677-G-A, CADD 5.47
- S57Y (p.Ser57Tyr), rs2148027642, ClinGen CA411279628, ClinVar RCV001975722, ClinVar RCV004774574, AlphaMissense 0.36, MetaLR 0.20, Uncertain significance, Familial focal epilepsy with variable foci; not provided
- L58F (p.Leu58Phe), gnomAD 22-31760681-C-T, CADD 23.00, PolyPhen-2 0.48
- K59E (p.Lys59Glu), rs2517797057, ClinGen CA411279646, ClinVar RCV003594975, Uncertain significance, Familial focal epilepsy with variable foci
- E60Q (p.Glu60Gln), rs2517797101, ClinGen CA411279657, ClinVar RCV004371100, Uncertain significance, Inborn genetic diseases
- E60G (p.Glu60Gly), gnomAD 22-31760688-A-G, CADD 27.00, PolyPhen-2 0.08
- E60E (p.Glu60Glu), rs550525739, gnomAD 22-31760689-A-G, CADD 9.05
- L62I (p.Leu62Ile), gnomAD 22-31760693-T-A, CADD 23.80, PolyPhen-2 0.91
- L62L (p.Leu62Leu), rs2148027760, gnomAD 22-31760695-A-G, CADD 9.54
- Q63* (p.Gln63Ter), rs372718805, ClinGen CA10195858, cosmic curated COSV99836, ClinVar RCV001942426, CADD 37.00, Pathogenic
- Q63R (p.Gln63Arg), NCI-TCGA Cosmic COSV5669, cosmic curated COSV56699, Variant assessed as somatic; moderate impact.
- K64N (p.Lys64Asn), gnomAD 22-31760701-G-C, CADD 24.80, PolyPhen-2 0.90
- K64K (p.Lys64Lys), rs1381635376, gnomAD 22-31760701-G-A, CADD 15.40
- T66S (p.Thr66Ser), rs1556523682, ClinGen CA411281098, ClinVar RCV000658938, Ensembl rs1556523682, AlphaMissense 0.50, MetaLR 0.12, Uncertain significance, not provided
- T66I (p.Thr66Ile), gnomAD 22-31764978-C-T, CADD 23.40, PolyPhen-2 0.20
- T66T (p.Thr66Thr), rs768489763, gnomAD 22-31764979-T-G, CADD 7.30
- I67V (p.Ile67Val), TOPMed rs2082694290
- S68G (p.Ser68Gly), rs1183087904, ClinGen CA411281159, ClinVar RCV002419756, ClinVar RCV004785690, CADD 26.60, PolyPhen-2 0.98, Uncertain significance, not provided; Inborn genetic diseases
- S68N (p.Ser68Asn), ESP rs369740612, TOPMed rs369740612, gnomAD rs369740612, CADD 26.50, PolyPhen-2 0.99, Uncertain significance, not provided
- S68S (p.Ser68Ser), rs774206363, gnomAD 22-31764985-T-C, CADD 11.00
- V69A (p.Val69Ala), cosmic curated COSV10455
- D70D (p.Asp70Asp), gnomAD 22-31764991-C-T, CADD 11.10
- Q71* (p.Gln71Ter), rs2148103123, ClinGen CA411281243, cosmic curated COSV56691, ClinVar RCV001885441, Pathogenic
- T72I (p.Thr72Ile), gnomAD 22-31764996-C-T, CADD 25.60, PolyPhen-2 0.94
- V73M (p.Val73Met), gnomAD 22-31764998-G-A, CADD 27.30, PolyPhen-2 0.99
- Q75H (p.Gln75His), ExAC rs761342718, TOPMed rs761342718, gnomAD rs761342718, CADD 24.30, PolyPhen-2 0.89
- Q75P (p.Gln75Pro), rs2082695082, ClinGen CA411281331, ClinVar RCV001044409, Ensembl rs2082695082, AlphaMissense 0.77, MetaLR 0.19, Uncertain significance, Familial focal epilepsy with variable foci
- Q75E (p.Gln75Glu), gnomAD 22-31765004-C-G, CADD 22.80, PolyPhen-2 0.61
- Q75Q (p.Gln75Gln), rs761342718, gnomAD 22-31765006-A-G, CADD 10.80
- V76A (p.Val76Ala), ExAC rs772678656
- V76M (p.Val76Met), gnomAD 22-31765007-G-A, CADD 23.90, PolyPhen-2 0.54
- F77L (p.Phe77Leu), rs2082695710, ClinGen CA411281396, cosmic curated COSV56704, ClinVar RCV004371103, AlphaMissense 1.00, MetaLR 0.27, Uncertain significance, Inborn genetic diseases
- R78G (p.Arg78Gly), TOPMed rs202233627, gnomAD rs202233627, Uncertain significance
- R78P (p.Arg78Pro), rs373578854, ClinGen CA10195880, ClinVar RCV000642489, ClinVar RCV002449018, CADD 24.80, PolyPhen-2 0.29, Conflicting interpretations, Inborn genetic diseases; Familial focal epilepsy with variable foci; not provide
- R78Q (p.Arg78Gln), rs373578854, ClinGen CA10195879, ClinVar RCV002231814, ESP rs373578854, CADD 22.80, PolyPhen-2 0.01, Uncertain significance, Familial focal epilepsy with variable foci
- R78W (p.Arg78Trp), rs202233627, ClinVar RCV004573019, TOPMed rs202233627, gnomAD rs202233627, CADD 24.50, PolyPhen-2 0.78, Uncertain significance, not provided
- R78L (p.Arg78Leu), gnomAD 22-31765014-G-T, CADD 26.00, PolyPhen-2 0.13
- L79L (p.Leu79Leu), gnomAD 22-31765016-C-T, CADD 8.61
- P81S (p.Pro81Ser), gnomAD 22-31765022-C-T, CADD 22.50, PolyPhen-2 0.08
- Y82* (p.Tyr82Ter), rs2517906263, ClinGen CA2580099609, ClinVar RCV002875947, Pathogenic
- Y82F (p.Tyr82Phe), rs1417599681, ClinGen CA411281449, ClinVar RCV001755217, gnomAD rs1417599681, CADD 23.70, PolyPhen-2 0.28, Uncertain significance, not provided
- Q83* (p.Gln83Ter), rs2148103774, ClinGen CA411281463, cosmic curated COSV56706, ClinVar RCV001386733, Pathogenic
- Q83L (p.Gln83Leu), cosmic curated COSV56697, Uncertain significance, Familial focal epilepsy with variable foci
- Q83R (p.Gln83Arg), TOPMed rs1432383392
- D84D (p.Asp84Asp), rs183443533, gnomAD 22-31765033-T-C, CADD 10.40
- V85A (p.Val85Ala), cosmic curated COSV56701
- V85I (p.Val85Ile), gnomAD rs1359960069, Uncertain significance, DEPDC5-related disorder
- V85V (p.Val85Val), rs764133363, gnomAD 22-31765036-C-G, CADD 5.78
- Y86* (p.Tyr86Ter), 1000Genomes rs201609075, ESP rs201609075, ExAC rs201609075, TOPMed rs201609075, CADD 34.00, Likely benign
- Y86C (p.Tyr86Cys), rs377039864, ClinGen CA10195885, ClinVar RCV001211383, ClinVar RCV003284052, CADD 24.00, PolyPhen-2 0.00, Uncertain significance, Inborn genetic diseases; Familial focal epilepsy with variable foci
- Y86H (p.Tyr86His), rs752067925, ClinGen CA10195884, ClinVar RCV002047450, ExAC rs752067925, AlphaMissense 0.09, MetaLR 0.07, Uncertain significance, Familial focal epilepsy with variable foci
- Y86Y (p.Tyr86Tyr), rs201609075, gnomAD 22-31765039-T-C, CADD 7.84
- V87A (p.Val87Ala), NCI-TCGA Cosmic COSV5669, cosmic curated COSV56696, Variant assessed as somatic; moderate impact.
- N88D (p.Asn88Asp), rs144712084, ClinGen CA10195888, ClinVar RCV000525422, ClinVar RCV001288148, CADD 26.30, PolyPhen-2 0.91, Conflicting interpretations, Familial focal epilepsy with variable foci; not specified; Inborn genetic diseas
- N88T (p.Asn88Thr), Ensembl rs2148104171
- N88Y (p.Asn88Tyr), gnomAD 22-31765043-A-T, CADD 26.80, PolyPhen-2 0.98
- V89L (p.Val89Leu), NCI-TCGA Cosmic COSV5669, cosmic curated COSV56693, Variant assessed as somatic; moderate impact.
- V89V (p.Val89Val), rs780263580, gnomAD 22-31765048-C-A, CADD 9.15
- V90I (p.Val90Ile), rs768456731, ClinGen CA10195891, ClinVar RCV000254602, ClinVar RCV000656067, CADD 23.70, PolyPhen-2 0.04, Uncertain significance, Familial focal epilepsy with variable foci
- V90L (p.Val90Leu), ExAC rs768456731, TOPMed rs768456731, gnomAD rs768456731, CADD 25.70, PolyPhen-2 0.37, Pathogenic, in FFEVF1
- V90V (p.Val90Val), gnomAD 22-31765051-A-G, CADD 7.73
- D91G (p.Asp91Gly), gnomAD 22-31765053-A-G, CADD 26.30, PolyPhen-2 0.08
- D91D (p.Asp91Asp), gnomAD 22-31765054-C-T, CADD 9.44
- P92L (p.Pro92Leu), Ensembl rs977089582
- P92R (p.Pro92Arg), rs977089582, ClinGen CA411282008, ClinVar RCV003761038, ClinVar RCV004820305, AlphaMissense 0.39, MetaLR 0.21, Uncertain significance, Familial focal epilepsy with variable foci; not provided
- P92S (p.Pro92Ser), rs774294197, ClinGen CA411282001, ClinVar RCV000997903, ExAC rs774294197, CADD 24.60, PolyPhen-2 0.61, Uncertain significance, not provided
- P92T (p.Pro92Thr), ExAC rs774294197, TOPMed rs774294197, gnomAD rs774294197, CADD 24.80, PolyPhen-2 0.96, Uncertain significance
- P92P (p.Pro92Pro), rs1314316584, gnomAD 22-31765057-T-C, CADD 8.85
- K93N (p.Lys93Asn), rs2148104453, ClinGen CA411282024, ClinVar RCV002269570, Ensembl rs2148104453, CADD 40.00, PolyPhen-2 0.79, Uncertain significance, not provided
- K93K (p.Lys93Lys), gnomAD 22-31765060-G-A, CADD 31.00
Public DEPDC5 analysis runs
- DEPDC5 analysis run — DEPDC5 (2,181 variants) — completed 2026-08-19